NewcelX Ltd. (NCEL) shareholders
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| League Jinn Sarl Joint filing with Julien Ruggieri (25.30%) | 1,316,267 | 25.30% | 13D (active) | Apr 27, 2026 |
| Julien Ruggieri Joint filing with League Jinn Sarl (21.60%) | 988,996 | 21.60% | 13G (passive) | Oct 30, 2025 |
| Michel Revel | 940,787 | 20.20% | 13D (active) | Oct 30, 2025 |
| Ronald Hafner | 557,131 | 13.20% | 13D (active) | May 22, 2025 |
| Clover Wolf Capital - Limited Partnership Joint filing with Adi Wolf (7.50%) | 343,120 | 7.50% | 13G (passive) | Oct 30, 2025 |
| Ronen Twito | 272,399 | 6.00% | 13D (active) | Oct 30, 2025 |
| Alpha Capital Anstalt | 246,996 | 9.99% | 13G (passive) | Oct 10, 2024 |
| Armistice Capital, LLC Joint filing with Steven Boyd (9.99%) | 129,475 | 9.99% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NCEL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hrt Financial LP | 11,199 | 0.23% | $40.00K | New | 0.00% |
| Jones Financial Companies Lllp | 700 | 0.01% | $2.55K | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 9 | 0.00% | $33 | +8 | 0.00% |
| CoreCap Advisors, LLC | 3 | 0.00% | $11 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 4 | 0M | 0.2% | 2 / 1 | 0 / 2 | 0M | 0M |
| Q1 2026 | 4 | 0M | 0.0% | 3 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 1 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q3 2024 | 0 | 0M | 0.0% | 0 / 0 | 0 / 10 | 0M | 0M |
| Q2 2024 | 10 | 0M | 0.4% | 3 / 2 | 1 / 1 | 0M | 0M |
| Q1 2024 | 8 | 0M | 0.4% | 4 / 1 | 0 / 1 | 0M | 0M |
| Q4 2023 | 5 | 0M | 0.3% | 0 / 0 | 1 / 2 | 0M | 0M |
| Q3 2023 | 7 | 0M | 0.3% | 1 / 1 | 2 / 3 | 0M | 0M |
| Q2 2023 | 9 | 0M | 0.3% | 3 / 2 | 1 / 1 | 0M | 0M |
| Q1 2023 | 7 | 0M | 0.3% | 4 / 1 | 0 / 2 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michel Revel | CSO and Director, 10% owner | 957,530 | 19.96% | Apr 29, 2026 |
| Ronen Twito | Chairman and CEO, Director | 272,399 | 5.68% | Mar 18, 2026 |
| Kfir Molakandov | VP of R&D | – | – | Mar 18, 2026 |
| Omri Hagai | Chief Financial Officer | – | – | Mar 18, 2026 |
| Olivier Samuel | Director | 81,818 | 1.71% | Apr 29, 2026 |
| Tamar Galili | Director | – | – | Mar 18, 2026 |
| Alexander Zwyer | Director | – | – | Mar 18, 2026 |
| Eran Israel Iohan | Director | – | – | Mar 18, 2026 |
| Liora Oren | Director | – | – | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Olivier Samuel Director | Apr 27, 2026 | Buy | +81,818 | $2.75 | $225.00K | 81,818 |
| Michel Revel CSO and Director, 10% owner | Apr 27, 2026 | Buy | +54,545 | $2.75 | $150.00K | 957,530 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NewcelX's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?